Trial of Chiauranib Capsule on Pharmacokinetics to Assess the Effect of High Fat Diet in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 2, 2022

Primary Completion Date

June 28, 2022

Study Completion Date

June 28, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

Chiauranib

50mg po only once

Trial Locations (1)

21500

The First Affiliated Hospital of Suzhou University, Suzhou

Sponsors
All Listed Sponsors
collaborator

H & J CRO International, Inc.

INDUSTRY

lead

Chipscreen Biosciences, Ltd.

INDUSTRY